Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands

[1]  20th ISoP Annual Meeting “Integrated pharmacovigilance for safer patients” 8–10 November 2021 Muscat, Oman (Hybrid meeting) , 2021, Drug Safety.

[2]  David A. Drew,et al.  Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study , 2021, The Lancet Infectious Diseases.

[3]  J. Gee,et al.  Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. , 2021, JAMA.

[4]  V. Simon,et al.  Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine , 2021, The New England journal of medicine.

[5]  J. Moon,et al.  Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals , 2021, The Lancet.

[6]  Nguyen H. Tran,et al.  Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials , 2021, The Lancet.

[7]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[8]  Andrew T. Levin,et al.  Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications , 2020, European Journal of Epidemiology.

[9]  Xiaolong Qi,et al.  Real estimates of mortality following COVID-19 infection , 2020, The Lancet Infectious Diseases.

[10]  A. Didierlaurent,et al.  The how’s and what’s of vaccine reactogenicity , 2019, npj Vaccines.

[11]  V. Appay,et al.  Aging of the immune system: Focus on inflammation and vaccination , 2016, European journal of immunology.

[12]  L. Härmark,et al.  Web-based intensive monitoring of adverse events following influenza vaccination in general practice. , 2015, Vaccine.

[13]  S. Klein,et al.  Sex-based differences in immune function and responses to vaccination. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  Espen Røysamb,et al.  Attrition and generalizability in longitudinal studies: findings from a 15-year population-based study and a Monte Carlo simulation study , 2012, BMC Public Health.

[15]  E. Hak,et al.  Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring. , 2011, Vaccine.

[16]  Linda Veronica Dae-Hee Härmark,et al.  Web-based intensive monitoring: a patient based pharmacovigilance tool , 2008 .